Fresenius SE & Co KGaA FRE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €33.87
- Day Range
- €33.81–34.38
- 52-Week Range
- €19.98–47.31
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €19.32 Bil
- Volume/Avg
- 2,200 / 896,083
Key Statistics
- Price/Earnings (Normalized)
- 6.45
- Price/Sales
- 0.88
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Large Core
- Total Number of Employees
- 175,771
- Website
- https://www.fresenius.com
Competitors
Valuation
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.45 | 12.57 | 16.58 |
Price/Book Value | 1.02 | 2.42 | 21.60 |
Price/Sales | 0.88 | 1.23 | 1.17 |
Price/Cash Flow | 26.69 | 12.11 | 7.15 |
Price/Earnings
FRE
BAX
DVA
Financial Strength
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Quick Ratio | 0.70 | 0.77 | 1.06 |
Current Ratio | 1.29 | 1.40 | 1.16 |
Interest Coverage | 2.72 | 0.63 | 4.60 |
Quick Ratio
FRE
BAX
DVA
Profitability
|
Metric
|
FRE
|
BAX
|
DVA
|
|---|---|---|---|
Return on Assets (Normalized) | 2.86% | 5.24% | 7.26% |
Return on Equity (Normalized) | 8.35% | 19.49% | 128.03% |
Return on Invested Capital (Normalized) | 4.82% | 7.74% | 11.03% |
Return on Assets
FRE
BAX
DVA
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Dbbpwpvh | Pvzgsh | $101.7 Bil | |||
| Fresenius SE & Co KGaA
FSNUF
| — | Tpgrq | $21.1 Bil | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Zlwhyg | $21.1 Bil | |||
| Tenet Healthcare Corp
THC
| Mjzgkyr | Fkqmd | $15.0 Bil | |||
| Universal Health Services Inc Class B
UHS
| — | Zzzbg | $14.4 Bil | |||
| Bangkok Dusit Medical Services PCL ADR
BDUUY
| — | Qyg | $14.1 Bil | |||
| DaVita Inc
DVA
| Rzthzlrb | Snvgfng | $13.5 Bil | |||
| Fresenius Medical Care AG
FMCQF
| — | Hzsthc | $12.2 Bil | |||
| Fresenius Medical Care AG ADR
FMS
| Mwr | Mdfsxd | $12.2 Bil | |||
| Encompass Health Corp
EHC
| — | Ndtcy | $9.5 Bil |
United States